Associated Papers
Whole exome sequencing reveals an FCGBP variant associated with spontaneous intraabdominal hemorrhage in severe acute pancreatitis.
Tang QY et al.
Imetaomics, 2025
Single-Nucleotide Polymorphisms Associated with Mercury Levels and Neurological Symptoms: An Overview.
Perini JA et al.
Toxics, 2024
Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling.
Deserranno K et al.
Frontiers in Pharmacology, 2023
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Liu Z et al.
European Journal of Clinical Pharmacology, 2022
Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7.
Sevrioukova IF
International Journal of Molecular Sciences, 2021
Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder.
Medhasi S et al.
Neuropsychiatric Disease and Treatment, 2016
Variability in Expression of CYP3A5 in Human Fetal Liver.
Vyhlidal CA et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2015
Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.
Preissner SC et al.
Plos One, 2013
CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility.
Kristiansen W et al.
International Journal of Andrology, 2011
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Lubomirov R et al.
Pharmacogenetics and Genomics, 2010
Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population.
Lee SS et al.
Molecular Biology Reports, 2010
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M et al.
Pharmacology & Therapeutics, 2007
Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations.
Du J et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2007
CYP3A phenotypes and genotypes in North Indians.
Rais N et al.
European Journal of Clinical Pharmacology, 2006
Japanese single nucleotide polymorphism database for 267 possible drug-related genes.
Iida A et al.
Cancer Science, 2006
Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.
Rodríguez-Antona C et al.
Clinical Pharmacology and Therapeutics, 2005
[SNP collection, pharmacogenomics, and the future of drug therapy].
Iida A et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2002
906 variations among 27 genes encoding cytochrome P450 (CYP) enzymes and aldehyde dehydrogenases (ALDHs) in the Japanese population.
Saito S et al.
Journal of Human Genetics, 2002
Sequence diversity and haplotype structure at the human CYP3A cluster.
Thompson EE et al.
The Pharmacogenomics Journal, 0